Monday, September 22, 2014   

China to put Glaxo investigators on trial
(07-29 16:28)

A Shanghai court says American and British investigators who worked for drug maker GlaxoSmithKline will stand trial Aug. 8 on charges of illegally obtaining information on Chinese citizens.
The Shanghai No. 1 Intermediate People's Court said Tuesday that Yingzeng Yu and her husband Peter Humphrey will have a "public trial.'' Authorities had told U.S. and British diplomats they would be barred because the trial involved secret information but later reversed that decision.
Yu and Humphrey were detained last year and accused of improperly obtaining information such as home addresses of Chinese citizens for reports sold to corporate clients.
Yu and Humphrey worked for Glaxo, which faces an investigation into allegations it bribed doctors to use its medicines. Authorities have given no indication whether the two cases are connected. --AP   
Other China breaking news:
Double suicide in Hunan school (1 hr 27 mins ago)
China reveals cases of torture in police detention (2 hrs 47 mins ago)
Taiwan begins clear-up in aftermath of tropical storm (09-22 14:31)
Two dead in Xinjiang blasts (09-22 11:11)
Dalai Lama hails Xi as 'more open-minded' (09-18 15:31)
Road accident in Hebei kills 4 (09-18 14:56)
4 officials prosecuted for violations (09-18 11:38)
Taiwan holds biggest naval exercise in 25 years (09-17 17:59)
Jaycee Chan formally arrested (09-17 17:45)
Driver detained over fatal truck crash (09-17 16:03)

More breaking news >>

© 2014 The Standard, The Standard Newspapers Publishing Ltd.
Contact Us | About Us | Newsfeeds | Subscriptions | Print Ad. | Online Ad. | Street Pts

 


Home | Top News | Local | Business | China | ViewPoint | CityTalk | World | Sports | People | Central Station | Spree | Features

The Standard

Trademark and Copyright Notice: Copyright 2014, The Standard Newspaper Publishing Ltd., and its related entities. All rights reserved.  Use in whole or part of this site's content is prohibited.   Use of this Web site assumes acceptance of the
Terms of Use, Privacy Policy Statement and Copyright Policy.  Please also read our Ethics Statement.